TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Apr 20, 2026
2 min read
72

Australian data centre operator NEXTDC Ltd plans to raise approximately A$2.2 billion in capital. The move is driven by a significant surge in demand for data centre capacity, primarily from hyperscale and artificial intelligence customers.
The fundraising consists of a fully underwritten A$1.5 billion pro-rata accelerated non-renounceable entitlement offer and an expanded A$1.7 billion hybrid securities offering. The company reported a 60% increase in pro forma contracted utilisation since December, reaching 667MW, with its forward order book growing by 83% to 544MW.
New shares will be offered at A$12.70 each, representing an 8.6% discount to the theoretical ex-rights price. The proceeds will fund the accelerated development of its S4 facility in Western Sydney. Consequently, capital expenditure guidance for fiscal 2026 has been increased to as much as A$3 billion, reflecting strong long-term growth visibility.
NEXTDC anticipates that contracted earnings from its existing capacity will eventually exceed A$1 billion. This fundraising positions the company to meet escalating demand and solidify its market leadership in the region's rapidly growing digital infrastructure sector.
Q: Why is NEXTDC raising capital?
A: To fund the accelerated development of its data centres, including the S4 facility in Western Sydney, to meet surging demand from AI and hyperscale clients.
Q: How much capital is NEXTDC raising?
A: The company plans to raise approximately A$2.2 billion through a combination of an entitlement offer and a hybrid securities offering.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

01 May 2026
Canada Approves Apotex Generic Ozempic Drug

01 May 2026
RRE Ventures SPAC Raises $250M in Nasdaq IPO